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A B S T R A C T
Background
A diagnosis of head and neck cancer, like many other cancers, can lead to significant psychosocial distress. Patients with head and neck
cancer can have very specific needs, due to both the location of their disease and the impact of treatment, which can interfere with basic
day-to-day activities such as eating, speaking and breathing. There is a lack of clarity on the effectiveness of the interventions developed
to address the psychosocial distress experienced by patients living with head and neck cancer.
Objectives
To assess the effectiveness of psychosocial interventions to improve quality of life and psychosocial well-being for patients with head
and neck cancer.
Search methods
We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled
Trials (CENTRAL); PubMed; EMBASE; CINAHL; Web of Science; BIOSIS Previews; Cambridge Scientific Abstracts; ICTRP and
additional sources for published and unpublished trials. The date of the most recent search was 17 December 2012.
Selection criteria
We selected randomised controlled trials and quasi-randomised controlled trials of psychosocial interventions for adults with head and
neck cancer. For trials to be included the psychosocial intervention had to involve a supportive relationship between a trained helper
and individuals diagnosed with head and neck cancer. Outcomes had to be assessed using a validated quality of life or psychological
distress measure, or both.
Data collection and analysis
Two review authors independently selected trials, extracted data and assessed the risk of bias, with mediation from a third author where
required. Where possible, we extracted outcome measures for combining in meta-analyses. We compared continuous outcomes using
eithermean differences (MD) or standardisedmean differences (SMD) and 95%confidence intervals (CI), with a random-effectsmodel.
We conducted meta-analyses for the primary outcome measure of quality of life and secondary outcome measures of psychological
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distress, including anxiety and depression. We subjected the remaining outcome measures (self esteem, coping, adjustment to cancer,
body image) to a narrative synthesis, due to the limited number of studies evaluating these specific outcomes and the wide divergence
of assessment tools used.
Main results
Seven trials, totaling 542 participants, met the eligibility criteria. Studies varied widely on risk of bias, interventions used and outcome
measures reported. From these studies, there was no evidence to suggest that psychosocial intervention promotes global quality of
life for patients with head and neck cancer at end of intervention (MD 1.23, 95% CI -5.82 to 8.27) as measured by the European
Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). This quality of life tool
includes five functional scales, namely cognitive, physical, emotional, social and role. There was no evidence to demonstrate that
psychosocial intervention provides an immediate or medium-term improvement on any of these five functional scales. From the data
available, there was no significant change in levels of anxiety (SMD -0.09, 95% CI -0.40 to 0.23) or depression following intervention
(SMD -0.03, 95% CI -0.24 to 0.19). At present, there is insufficient evidence to refute or support the effectiveness of psychosocial
intervention for patients with head and neck cancer.
Authors’ conclusions
The evidence for psychosocial intervention is limited by the small number of studies, methodological shortcomings such as lack of
power, difficulties with comparability between types of interventions and a wide divergence in outcome measures used. Future research
should be targeted at patients who screen positive for distress and use validated outcome measures, such as the EORTC scale, as a
measure of quality of life. These studies should implement interventions that are theoretically derived. Other shortcomings should
be addressed in future studies, including using power calculations that may encourage multi-centred collaboration to ensure adequate
sample sizes are recruited.
P L A I N L A N G U A G E S U M M A R Y
Psychosocial interventions for patients with head and neck cancer
There is a steady rise in the number of people being diagnosed with head and neck cancer. It is more common in men over 60, but
the incidence rate is rising, especially in younger adults (men and women under 40). Survival rates for some cancers in the head and
neck area are over 50%. As a result, the quality of life of head and neck cancer patients and how they adjust to life after treatment are
becoming increasingly important. Unfortunately life can change greatly for many people following treatment of head and neck cancer
due to the obvious change in their appearance, or changes in how they speak and eat. Also, this patient group is known to have high
rates of smoking and alcohol use. This combination of more people living with and surviving head and neck cancer, and the high
degree of cancer-related issues, has led healthcare professionals to develop programmes to support patients with some of the problems
they may experience after treatment. The focus of these programmes is often on addressing emotional or social problems related to
the patient’s cancer and they are known as ’psychosocial interventions’. This review examines the evidence for the effectiveness of
psychosocial interventions to improve quality of life or psychosocial well-being.
We identified seven studies, with a total of 542 adult patients who had head and neck cancer. However, many of the studies had
shortcomings in their design or reporting. This has made it difficult to draw reliable conclusions.
Overall, this review did not find any improvement in general quality of life or in levels of anxiety and depression following psychosocial
intervention.
In conclusion, there was limited good-quality evidence in this area, making it difficult to draw conclusions about the effectiveness
of psychosocial interventions. Future good-quality research is required in this field and should target those in need of psychosocial
intervention, in order to guide service development.
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B A C K G R O U N D
Description of the condition
Head and neck cancer describes a range of tumours that arise in the
head and neck region, which includes the oral cavity, pharynx, lar-
ynx, nasal cavity, paranasal sinuses and salivary glands. The world-
wide incidence of head and neck cancer exceeds half amillion cases
annually, ranking it as the fifth most common cancer worldwide
(Harrison 2009). With ongoing developments in cancer diagnosis
and treatment, the overall survival rate for head and neck cancer
has improved marginally but mainly for those from higher socioe-
conomic backgrounds (CRUK 2011). Head and neck cancer is
strongly associated with certain lifestyle factors, mainly tobacco
smoking and alcohol consumption (Duffy 2007).
Cancer has a significant impact on the lives of people and is life-
disrupting on many levels. A diagnosis of head and neck cancer,
like any other cancer, brings with it significant psychosocial effects
including uncertainty and fear. Patients with head and neck cancer
have also very specific needs, due to the location of their disease.
Many patients face the reality of altered appearance, changes to
their speech, swallowing and breathing, and high levels of symp-
tomatology (pain, xerostomia, shoulder dysfunction). The burden
of head and neck cancer can manifest in psychosocial distress and
social isolation, which can have a negative impact on quality of life
(Semple 2008). The prevalence of psychological distress amongst
head and neck cancer patients is difficult to estimate, with reported
incidences of psychological morbidity varying from 12% to 45%,
depending on the criteria and diagnostic tool utilised (Frampton
2001; Haman 2008; Veer 2010).
As treatments for head and neck cancer develop, modest improve-
ment in survival rates is noted. This presents clinicians with a
growing challenge to devise and test interventions that can help
people manage the side effects of treatment and the psychosocial
impact on their lives.
Description of the intervention
Over the past three decades a variety of psychosocial interventions
have been developed to help head and neck cancer patients cope
with the emotional and social impact of the condition. Psychoso-
cial intervention refers to any attempt to provide solutions to the
challenges individuals may encounter to their psychological well-
beingwhen interactingwith any element of the social environment
(Bessell 2009).Holland 1982 described the goals of these interven-
tions as being to decrease feelings of alienation, lessen feelings of
isolation, helplessness and hopelessness, and to assist in clarifying
misperceptions andmisinformation. These interventions may also
promote self management by equipping and empowering patients
to take more responsibility for getting well. These interventions
vary considerably in their theoretical premise, complexity, content
and mode of delivery.
How the intervention might work
Fawzy 1995 reported on four main types of psychosocial interven-
tions which include: psychoeducational, psychotherapy (individ-
ual), cognitive behavioural training and group interventions.
• Psychoeducational interventions vary in the amount of
psychosocial information or coping instruction and behavioural
training they provide, but the emphasis is generally on educating
patients on the disease process and how to cope with the disease.
• Psychotherapy is generally within a one-to-one interaction
between a therapist and patient. The aim of psychotherapy is to
help the patient reduce distress, gain a sense of mastery over the
situation and help in overcoming the practical problems.
• Cognitive behavioural therapy involves identifying and
correcting negative thoughts, feelings and behaviours that
contribute to psychosocial difficulties. Behavioural and cognitive
techniques are employed and are aimed at improving emotional
and functional adjustment.
• Group interventions centre on two types of support groups
which are either led by a professional or by patients themselves,
often referred to as peer support groups. Group interventions are
thought to influence self esteem by normalising the experience
and reduce feelings of isolation or abnormality, promote
adjustment and add meaning to life through helping others and
instillation of hope by social comparisons.
Why it is important to do this review
It is currently recommended in UK government policy that all pa-
tients with a cancer diagnosis should “undergo systematic psycho-
logical assessment at key points and have access to appropriate psy-
chological support” (NICE 2004, page 13). The National Cancer
Comprehensive Network (NCCN) in the USA advocates that all
cancer patients should be screened for psychological distress, with
the premise that a number may benefit from further psychosocial
interventions (Holland 2005). Despite this flourishing body of
literature identifying the importance of assessment and interven-
tion, there is a lack of evidence from systematic reviews regarding
the effectiveness of psychosocial interventions and which type of
interventions are most effective for different groups of patients.
A previous integrative review of the head and neck cancer lit-
erature tentatively suggested that psychosocial interventions im-
proved quality of life, had a positive impact on emotional ad-
justment and improved coping skills, but many of these studies
hadmethodological flaws (Semple 2004). In recent years there has
been an increase in the number of studies that have developed and
tested interventions to improve quality of life, reduce distress and
enhance adjustment for patients with head and neck cancer; there-
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fore it is reasonable to suggest that a higher standard of method-
ology and reporting should be evident in this systematic review.
This review will systematically assess the best available evidence
on the effectiveness of psychosocial interventions for patients with
head and neck cancer. This will provide clinicians with reliable in-
formation on the most appropriate interventions, thus promoting
adjustment and quality of life for a patient population that has a
considerable disease burden.
O B J E C T I V E S
To assess the effectiveness of psychosocial interventions for adults
with head and neck cancer.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) andquasi-RCTsof psychoso-
cial interventions for patients with a head and neck cancer diagno-
sis. ’Quasi-RCT’ refers to when themethod of allocation is known
but not considered as strictly random, such as alternation, date of
birth or medical record number.
Types of participants
Adults (aged 18 or older) with any type or stage of head and neck
cancer. There was no restriction on gender, ethnicity, treatment
modality, type of setting or stage in the cancer journey.
Types of interventions
Psychosocial interventions included: psychoeducational, psy-
chotherapy (individual), cognitive behavioural training, support-
ive and group interventions. For individual or group interventions
to be included, they must have comprised of a face-to-face com-
ponent; but may have been supplemented by written, telephone
or computer-assisted learning (demonstrating completion of in-
tervention), at home or in a healthcare setting (or a combination
of these) by lay or trained personnel (or a combination of both).
Interventions that were solely based on the distribution of infor-
mational material (without input from trained or lay personnel)
and those that were physical in nature, such as exercise or massage
alone, were excluded from this review. Control groups included
those who had not received the psychosocial intervention being
tested or who had received ’standard care’.
Types of outcome measures
Primary outcomes
Quality of life, as measured by an established and/or validated
tool, for example, the European Organisation for Research and
Treatment of Cancer (EORTC) QLQ-C30.
Secondary outcomes
The secondary outcome measures included various facets of psy-








• Locus of control
• Adjustment/adaptation
• Life satisfaction
• Satisfaction with the intervention
• Fear of recurrence
All primary and secondary outcome measures must be assessed
using an established and/or validated scale, for example: Univer-
sity of Washington Quality of Life (UWQOL), General Health
Questionnaire (GHQ), Hospital Anxiety and Depression Scale
(HADS), Rotterdam Symptom Checklist, Mental Adjustment to
Cancer Scale, Impact of Events Scale and Derriford Appearance
Scale.
Search methods for identification of studies
We conducted systematic searches for randomised controlled tri-
als and quasi-RCTs. There were no language, publication year or
publication status restrictions. The date of the search was 17 De-
cember 2012.
Electronic searches
We searched the following databases from their inception for
published, unpublished and ongoing trials: the Cochrane Ear,
Nose and Throat (ENT) Disorders Group Trials Register; the
Cochrane Central Register of Controlled Trials (CENTRAL, The
Cochrane Library 2012, Issue 12); PubMed; EMBASE; CINAHL;
PsycINFO;LILACS;KoreaMed; IndMed; PakMediNet;CABAb-
stracts; Web of Science; BIOSIS Previews; ClinicalTrials.gov; IC-
TRP; National Cancer Institute Trials database; Cancer Research
UK trials database and Google.
We modelled subject strategies for databases on the search strat-
egy designed for CENTRAL. Where appropriate, we combined
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subject strategies with adaptations of the highly sensitive search
strategy designed by The Cochrane Collaboration for identify-
ing randomised controlled trials and controlled clinical trials (as
described in theCochrane Handbook for Systematic Reviews of In-
terventions Version 5.1.0, Box 6.4.b. (Handbook 2011)). Search
strategies for major databases including CENTRAL are provided
in Appendix 1.
Searching other resources
We scanned the reference lists of identified publications for addi-
tional trials and contacted trial authors where necessary. In addi-
tion, we searched PubMed, TRIP database and Google to retrieve
existing systematic reviews relevant to this systematic review, so
that we could scan their reference lists for additional trials. We
searched for conference abstracts using the Cochrane Ear, Nose
and Throat Disorders Group Trials Register.
Research in progress





No language restrictions were placed on trials (unless accurate
translation proved problematic). Initially foreign language ab-
stracts were translated and measured against the inclusion and ex-
clusion criteria. Where necessary, methods, results and discussion
sections were translated for inclusion in the review, thus enabling
completion of the data extraction form.
Data collection and analysis
Selection of studies
After removing duplicates, we gave all titles and abstracts of se-
lected studies, retrieved through the electronic searches, an identi-
fication code. Pairs of review authors (CS, KP, AN, EMcC, MM)
examined the remaining abstracts and independently screened for
suitability, according to the following criteria:
• RCT or quasi-RCT;
• psychosocial intervention (based on definition in
Background section and confirmed by CS, AN or both);
• adult (aged 18+) with head and neck cancer; and
• outcome to include a validated measure of quality of life or
psychosocial functioning.
Grey literature such as dissertations, theses and conference and
poster abstracts were excluded. When it was unclear whether the
trial clearly meet the above inclusion criteria, we obtained the full
text of the article and checked it for eligibility.When discrepancies
arose regarding the inclusion/exclusion of trials between two re-
view authors this was resolved by discussion or, when necessary, by
appeal to a third review author. A list of excluded studies and rea-
son for exclusion is included inCharacteristics of excluded studies.
Data extraction and management
Two review authors independently extracted data from the original
reports onto pre-designed data extraction forms. Data extraction
forms were completed by translators from the Cochrane ENT
Disorder Group for one German study and three Chinese studies.
Extracted data included the following.
• GENERAL: title of paper, author, year of publication, title,
source, country and language of publication, type of report.
• PARTICIPANT: age, gender, ethnicity, cancer stage,
location of tumour, treatment modality, sample size and
distribution in each arm of the trial, inclusion and exclusion
criteria.
• INTERVENTION: description of intervention, mode of
delivery, setting, length and frequency of intervention, healthcare
professional delivering the intervention, duration of follow-up,
control intervention characteristics.
• METHODOLOGICAL QUALITY: see below.
• OUTCOMES: names of the validated tools used and
results pertaining to the outcome measures.
Assessment of risk of bias in included studies
The review authors worked in pairs to assess the methodological
quality of the studies selected and, using a quality appraisal check-
list, coded them as follows:
Random allocation (selection bias)
• Low risk, e.g. computer-generated random sequence or
table of random numbers
• High risk, e.g. hospital ID, date of birth or surname
• Unclear, e.g. insufficient information about the sequence
generation process
Allocation concealment (selection bias)
• Low risk, e.g. allocation concealment could not be foretold
• High risk, e.g. researcher/healthcare provider aware of the
assignment arm of the participant
• Unclear, e.g. insufficient information to permit judgement
of ’low’ or ’high’
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Blinding (detection bias)
Blinding of participants to this type of intervention is extremely
challenging and in most cases impossible. Nevertheless the out-
come assessors can be blinded and this will be coded as:
• Low risk, e.g. blinding ensured and unlikely to be broken
• High risk, e.g. no blinding of outcome assessors or could
have been broken
• Unclear, e.g. insufficient information to permit judgement
Incomplete data (attrition bias)
• Low risk, e.g. no missing outcome data or attrition rate/loss
to follow-up clearly accounted for
• High risk, e.g. imbalance of numbers or reasons for missing
data not provided
• Unclear, e.g. insufficient information to permit judgement
of ’high’ or ’low’
Selective reporting
• Low risk, e.g. primary and secondary outcome measures
have been reported in a pre-specified way
• High risk, e.g. not all of the study’s pre-defined outcome
measures have been reported or report fails to include results
from a key outcome that would be expected
• Unclear, e.g. insufficient information to permit judgement
of ’low risk’ or ’high risk’
Other sources of bias
• Low risk, e.g. free of other sources of bias
• High risk, e.g. potential sources of bias related to the
specific study design
• Unclear, e.g. insufficient information to assess whether an
important risk exists
When there was insufficient information we made attempts to
contact the study authors for clarification.
We used the information collected in the ’Risk of bias’ tool avail-
able in RevMan 5 (RevMan 2012) to assess the quality of each
study.
Measures of treatment effect
We entered data into RevMan 5. All the reported data in the in-
cluded studies were continuous. We extracted means and standard
deviations (SD) and, where appropriate, converted standard errors
(SE) into standard deviations for meta-analysis using 95% confi-
dence intervals and a random-effects model. When different scales
were used to measure the same outcome, we used the standardised
mean difference (SMD) instead of the mean difference (MD).
Dealing with missing data
When missing data or study discrepancies were evident, we made
attempts (where possible) to contact the original investigators for
further information.
Assessment of heterogeneity
Studies in this review were derived from a heterogeneous group
of psychosocial interventions which differed in their theoretical
premises. However, when the essential characteristic of the inter-
vention was based on psychosocial elements to improve well-be-
ing, this rendered it appropriate to combine data assuming they
were assessing the same outcome. We assessed heterogeneity be-
tween studies using the I2 statistic. We considered an I2 value
greater than 50% as indicative of heterogeneity. Where marked
heterogeneity was found, we investigated sources. In the event of
substantial clinical, methodological or statistical heterogeneity, we
did not combine study results by means of meta-analysis. We used
random-effects models for all meta-analyses.
Assessment of reporting biases
We did not generate a funnel plot because there were too few
studies in the meta-analysis carried out in this review.
Data synthesis
Some outcomes were measured by a range of scales, e.g. depres-
sion. We first conducted a meta-analysis of data from the same
scale, followed by meta-analyses combining data from different
scales. We used SMD with a random-effects model to counteract
heterogeneity in these studies. Where there were insufficient data
reported, we carried out qualitative synthesis.
Subgroup analysis and investigation of heterogeneity
It was our intention to conduct the following subgroup analyses
where data were available.
• Stage in cancer journey (potentially curative, palliative)
• Healthcare professional delivering intervention (nurse,
psychologist, counsellor, allied health professional)
• Method of delivery (individual, group, telephone)
• Duration: short-term (i.e. less than three months),
medium-term (i.e. three to six months) or long-term (more than
six months)
• Separate analysis on studies by type as described in the
Background section (Fawzy 1995)
When the data had been extracted it was clear that insufficient
data were available to conduct these subgroup analyses.
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Sensitivity analysis
When higher-risk studies were identified by the ’Risk of bias’ tool
we conducted a sensitivity analysis, including only those studies
with suspected low risk of bias. If a study was initially determined
as having an ’unclear’ risk of bias due to lack of information on
what happened in the study, then we sought further clarity from
the authors.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
Figure 1 illustrates the process of study selection for the review
and was lasted updated on 17 December 2012. From the elec-
tronic searches we retrieved 1035 references, although this number
dropped to 851 references after duplicates were removed. After an
initial subject/title screen 241 references remained. Two members
of the review team independently examined the abstracts of the
remaining 241 papers to remove obviously irrelevant studies that
were:
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Figure 1. Process of sifting search results and selecting studies for inclusion.
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• guidelines or a discussion paper and NOT a research paper;
• reviews or meta-analyses;
• in children and not adults;
• in non-cancer patients;
• prevention or screening papers.
Following this, we scrutinised 48 full papers and disregarded a
further 27 (e.g. grey literature). Three studies were identified as
ongoing (see Characteristics of ongoing studies). We formally ex-
cluded 11 studies for one of the following reasons:
• not RCTs or quasi-RCTs;
• outcomes determined using non-validated tools;
• focus of the intervention was not psychosocial;
• participants were not adults diagnosed with head and neck
cancer.
Seven studies were deemed suitable for inclusion.
Included studies
Of the seven studies that were included, two were conducted in
Canada (Allison 2012; Katz 2004), three in China (Bai 2004; Fan
2006; Yongqin 2009), one in the USA (Duffy 2006) and one in
the UK (Humphris 2012). Four of these studies were written in
English (Allison 2012; Duffy 2006; Humphris 2012; Katz 2004)
and three in Chinese (Bai 2004; Fan 2006; Yongqin 2009). Data
extraction forms for the three Chinese papers were completed by a
Chinese author for the Cochrane Ear, Nose and Throat Disorder
Group.
Design
All of the included studies in the review were RCTs, therefore
all seven reported baseline assessment and a post-intervention as-
sessment for the experimental and control groups (Allison 2012;
Bai 2004; Duffy 2006; Fan 2006; Humphris 2012; Katz 2004;
Yongqin 2009). All studies had one post-intervention assessment
point, with the exception ofHumphris 2012 andKatz 2004 which
had two. All of the studies had one experimental arm.
Participants
The included studies recruited between 19 (Katz 2004) and 184
(Duffy 2006) participants. A total of 542 participants were re-
cruited from the seven included studies. The mean number of
participants was 77. Fan 2006 did not report on gender, therefore
from the remaining six studies there were 364 male and 143 fe-
male participants. An overview of each study can be found in the
Characteristics of included studies table.
Disease characteristics
All studies excluded participants who were in a terminal phase
of their illness/distant metastasis. Some of the studies included
participants with a range of tumour sites within the head and neck
region (n = 245) (Allison 2012; Duffy 2006), whereas participants
in Bai 2004 and Fan 2006 had solely nasopharyngeal cancer (n
= 117). Participants in Humphris 2012 and Katz 2004 had a
diagnosis of oral cancer (n = 96) and the Yongqin 2009 cohort
had laryngeal or hypopharyngeal carcinoma (n = 84).
Psychological screening and inclusion/exclusion criteria
Two of the studies (Allison 2012; Duffy 2006) screened for psy-
chological distress prior to accrual. Allison 2012 defined psycho-
logical distress as a score of more than seven on the anxiety and/
or depression scale of the Hospital Anxiety and Depression Scale
(HADS) (Zigmond 1983), with the aim of targeting interventions
for those with pre-existing levels of distress. Duffy 2006 included
participants who screened positive for one or more of three health
problems: smoking, alcohol or depression. Study eligibility for
probable depression was defined as a score of four or more on the
Geriatric Depression Scale-Short Form (Sheikh 1986).
Four trials excluded participants with a history of psychological
problems (Allison 2012; Duffy 2006; Fan 2006;Humphris 2012).
One specifically excluded those who had previously been diag-
nosed with depression and were currently undergoing any antide-
pressive therapy (Allison 2012). Both Duffy 2006 and Humphris
2012 excluded participants with unstable psychiatric/mental con-
ditions such as suicidal ideation/acute psychosis, whereas Fan 2006
excluded any participants with a history of mental illness.
Intervention
A number of different categorisations of psychosocial interven-
tion are used to enhance adjustment to cancer. As noted earlier,
Fawzy 1995 reported on four main types of psychosocial inter-
vention, which include: psychoeducational, psychotherapy (indi-
vidual), cognitive behavioural training and group interventions.
Nonetheless, in practice not all the psychosocial interventions fit
neatly into these different categories. For example, psychoeduca-
tion is often a component in cognitive behavioural interventions
and a cognitive behavioural intervention could be delivered in a
group format. Despite this, the studies within a systematic review
need to be considered homogenous to ensure that a combined anal-
ysis of pooled estimates is valid. Therefore, this review is founded
on the principle that a psychosocial intervention is a function of a
supportive relationship between a ’trained helper’ and an individ-
ual diagnosed with cancer, using some specific technique(s) that
has a potential to alter or change psychological constructs.
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The supportive interaction between a ’trained helper’ and an in-
dividual participant is evident in all included studies, which had
the common aim of improving quality of life and decreasing psy-
chosocial distress following a diagnosis of head and neck cancer.
None of the included studies used group, family or couple-based
therapy. However, the theoretical bases within the interventions
varied considerably. Two studies referred to the intervention as
psychoeducation (Allison 2012; Katz 2004). Five studies described
utilising CBT or recognised different aspects of the CBTmodel to
form part of the psychosocial intervention (Bai 2004; Duffy 2006;
Fan 2006; Humphris 2012; Yongqin 2009). Three studies stated
that they combined physical exercise with the psychosocial inter-
vention (Bai 2004; Fan 2006; Yongqin 2009) to promote psycho-
logical well-being, whilst Duffy 2006 included pharmacological
intervention if required.
Furthermore, the Katz 2004 study took the form of a brief,
preparatory intervention timed immediately before surgery for oral
cancer, with a further supportive session on postoperative day two
or three. The other studies were designed to address psychosocial
distress experienced by people who had completed treatment for
head and neck cancer (Allison 2012; Bai 2004; Duffy 2006; Fan
2006; Humphris 2012; Yongqin 2009).
Frequency and mode of intervention delivery
There was considerable heterogeneity regarding duration and
mode of intervention delivery in these studies. Nonetheless, all of
the studies had a face-to-face component of the intervention deliv-
ered by a professional. Two studies (Duffy 2006; Katz 2004) had
one face-to-face contact, supplemented with telephone contacts.
Duffy 2006 had the initial assessment conducted face-to-face, fol-
lowed by 9 to 11 telephone sessions, whereas the first interven-
tion session in Katz 2004 was via telephone and the second ses-
sion was delivered face-to-face. These two studies supplemented
their intervention with printed material. Katz 2004 produced a
psychoeducational booklet (95 pages) and Duffy 2006 had a de-
tailed workbook with CBT exercises. Allison 2012 also provided
a manual, plus audio material and music for relaxation.
Interventions were delivered by a variety of professionals. The ma-
jority of studies referred to trained therapists delivering the inter-
vention (Allison 2012; Duffy 2006; Fan 2006; Humphris 2012).
In three studies it was a nurse who delivered the intervention
(Duffy 2006; Humphris 2012; Katz 2004). In Fan 2006, a mul-
tidisciplinary team delivered the intervention. Three studies did
not provide information on the discipline of the professionals in-
volved (Allison 2012; Bai 2004; Yongqin 2009).
Control groups
In all seven studies participants had been randomised to either
the intervention or control group. Nonetheless, the control groups
differed across the studies, as five studies had standard usual care
as the control (Bai 2004; Fan 2006; Humphris 2012; Katz 2004;
Yongqin 2009). In the Allison 2012 study, the control group had
an attention placebo (i.e. received a similar number of contacts
and were allowed to discuss cancer-related issues) and Duffy 2006
used enhanced usual care to include a brief assessment and coun-
selling session with onward referrals as necessary for supportive/
psychiatric services as their control group.
Outcomes
A wide variety of outcomes measures were used in the seven stud-
ies, measured at different time points and they also varied in the
length of follow-up time. Nevertheless, each study either included
a quality of life measure (Bai 2004; Fan 2006; Humphris 2012;
Katz 2004; Yongqin 2009) and/or psychological distress measure
(Allison 2012; Duffy 2006; Humphris 2012; Katz 2004). Qual-
ity of life was measured in five out of the seven included stud-
ies. Three studies (Bai 2004; Humphris 2012; Katz 2004) used
the extensively validated European Organisation for Research and
Treatment of Cancer (EORTC) QLQ-C30 (Aaronson 1993) to
measure health-related quality of life. The EORTC QLQ-C30 is
a widely used and validated health-related quality of life measure
consisting of five functional scales (physical, role, cognitive, emo-
tional and social), a separate quality of life domain and three symp-
tom scales measuring fatigue, pain and emesis. Fan 2006 modified
the EORTC QLQ-C30 and Yongqin 2009 used a quality of life
tool for Washington medical college students. Therefore, we did
not extract from either of these two studies for the meta-analy-
sis. The three studies that used the EORTC QLQ-C30 all had a
relatively short-term post-intervention measuring point of either
three or four months (Bai 2004; Humphris 2012; Katz 2004).
Four studies measured depression (Allison 2012; Duffy 2006;
Humphris 2012; Katz 2004) but there was variation in the tools
used. Two studies (Allison 2012; Humphris 2012) used the Hos-
pital Anxiety and Depression Scale (HADS) (Zigmond 1983),
whilstDuffy 2006 used theGeriatricDepressionScale-Short Form
(Sheikh1986) andKatz 2004 usedCentre for Epidemiologic Stud-
ies Depression Scale (CES-D) (Radloff 1977). The medium-term
post-intervention measurement point for all four studies was be-
tween three and six months. Similarly, three of these studies mea-
sured anxiety between three and four months post-intervention,
with Allison 2012 and Humphris 2012 using the anxiety subscale
of the HADS, and Katz 2004 using the State-Trait Anxiety Inven-
tory (Spielberger 1980). Three studies provided appropriate data
for meta-analyses of quality of life (Bai 2004; Humphris 2012;
Katz 2004), whereas four provided data suitable for meta-anal-
yses of depression (Allison 2012; Duffy 2006; Humphris 2012;
Katz 2004), with three providing data for meta-analyses of anxiety
(Allison 2012; Humphris 2012; Katz 2004).
Excluded studies
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We formally excluded 11 studies after two review authors (CS,
MM) assessed the full texts (see Characteristics of excluded
studies). Reasons for excluding these studies were as follows:
• not a psychosocial intervention, e.g. educational material
alone, massage;
• not a RCT or quasi-RCT;
• mixed cancer sample but no separate data for head and neck
cancer participants;
• did not use a validated measure relevant to this review.
Risk of bias in included studies
We assessed all studies for risk of bias using the RevMan 5 ’Risk
of bias’ tool (RevMan 2012). We rated only one study included in
this review (Allison 2012) as being at an entirely low risk of bias.
The lack of important details for a number of the criteria, such
as method of random sequence generation and allocation, in the
remaining studies (Bai 2004; Duffy 2006; Fan 2006; Humphris
2012; Katz 2004; Yongqin 2009) precluded an adequate assess-
ment of their quality and the possibility of bias exists. We viewed
three studies as having high risk of bias for some aspects of the
assessment criteria (Bai 2004; Duffy 2006; Katz 2004). Details of
the ’Risk of bias’ assessment for the seven included studies are out-
lined in the Characteristics of included studies and summarised in
Figure 2 and Figure 3.
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
The inclusion criterion was that all studies should be randomised.
All seven included studies stated that randomisation had occurred.
Nonetheless, only three studies clearly stipulated that a method
of random sequence generation had taken place (Allison 2012;
Humphris 2012; Katz 2004). Allison 2012 and Humphris 2012
used a computer-generated randomisation list and Katz 2004 used
a random number table and we therefore classified them as low
risk of bias against this criteria. We classified the other studies as
’unclear’, having not clarified the method used.
With regard to allocation concealment, two studies clearly stated
a method that we considered to be at low risk of bias (Allison
2012; Humphris 2012). The generation of allocation sequence
for both of these studies was performed by an individual who was
independent of the project delivery (e.g. independently prepared
by the faculty statistician). The remaining studies did not provide
sufficient information on themethod of concealment and we have
reported them as at ’unclear’ risk of bias.
Blinding
Due to the nature of the intervention being delivered (i.e. psy-
chosocial care) it is difficult to blind the participant and person-
nel to the allocated intervention. Allison 2012 was the only study
which kept the participants blind to whether they were receiv-
ing the experimental or control intervention, being an attention
placebo.
The blinding of assessors (data collectors) was reported in four
studies, which we considered as at low risk bias (Allison 2012; Fan
2006;Humphris 2012; Katz 2004), however it was not mentioned
by Duffy 2006 and Yongqin 2009. We felt the Bai 2004 study to
have a high risk of bias for blinding of assessors as the researchers
and personnel worked collaboratively to accomplish outcome as-
sessment.
Incomplete outcome data
A high level of missing data or poor handling of missing data leads
to attrition bias. Fortunately for this review, when there was loss to
follow-up, all studies clearly recorded the number of participants
lost, with reasons provided (Allison 2012; Duffy 2006; Humphris
2012; Katz 2004). This demonstrated that attrition was balanced
across groups for these four studies. No loss of participants to
follow-up was reported in the three Chinese studies (Bai 2004;
Fan 2006; Yongqin 2009).
Selective reporting
There was no evidence of selective reporting in five of the seven
studies, with all outcome data reported (Allison 2012; Bai 2004;
Fan 2006; Katz 2004; Yongqin 2009). Duffy 2006 reported the
results of two scales (AUDIT and the Geriatric Depression Scale-
Short Form) as dichotomous data but through personal commu-
nication continuous data were provided for the depression out-
come measure (CES-D) to enable inclusion in the meta-analysis.
Humphris 2012 provided only a narrative summary of health-re-
lated quality of life data (EORTC QLQ-C30) but again through
personal communication continuous data were provided formeta-
analysis.
Other potential sources of bias
We assessed two studies (Duffy 2006; Katz 2004) as having addi-
tional risk of bias. Duffy 2006 received funding from a pharma-
ceutical company and two products which were part of the treat-
ment management protocol for the intervention are produced by
this company. Also, Katz 2004 had a small sample size (n = 19)
and used a large battery of questionnaires with multiple statistical
tests conducted.
Effects of interventions
The following section provides a description of the meta-analysis
for the primary outcome (quality of life) and the secondary out-
come (anxiety and depression). A brief narrative of the studies that
did not present adequate data for meta-analyses is also presented.
Of the studies with sufficient extractable data to be included in
the meta-analysis, all had follow-up periods varying between three
and six months and we considered this as medium-term follow-
up (Allison 2012; Bai 2004; Duffy 2006; Humphris 2012; Katz
2004).
Quality of life
Quality of life was measured in five out of the seven included
studies. Three studies (Bai 2004; Humphris 2012; Katz 2004)
used the extensively validated EuropeanOrganisation for Research
and Treatment of Cancer Quality of Life Questionnaire (EORTC
QLQ-C30) to measure health-related quality of life. Fan 2006
modified the EORTCQLQ-C30 andYongqin 2009 used a quality
of life tool for Washington medical college students. Therefore,
we did not extract data from either of these two studies for the
meta-analysis.
The EORTC QLQ-C30 is presented with five functional scales
(physical, role, cognitive, emotional and social), a separate global
quality of life domain and three symptom scalesmeasuring fatigue,
pain and emesis. We also conducted meta-analyses for the five
functional scales and the global quality of life domain for the three
studies with extractable data, in keeping with the objectives of
this review (Bai 2004; Humphris 2012; Katz 2004). There was
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no evidence of any benefit following psychosocial intervention on
global quality of life or on any of the five functional scales. A more
comprehensive review of the results is reported below under two
headings: medium-term follow-up and end of intervention.
Medium-term follow-up (three to six months post-
intervention)
The results of the meta-analysis for the physical function scale
of the EORTC QLQ-C30 at medium-term follow-up (three to
six months) can be viewed in Figure 4. This combines Bai 2004,
Humphris 2012 and Katz 2004, totaling 138 participants, and
demonstrates no statistically significant evidence favouring the in-
tervention group (mean difference (MD) 6.28, 95% confidence
interval (CI) -10.05 to 22.60) (Analysis 1.1). This finding must
be considered with caution due to the small number of studies,
small sample sizes, the large CI and the moderate degree of statis-
tical heterogeneity between study estimates (P = 0.06, I2 = 65%).
Also, Bai 2004 has been classified as being at high risk of bias, as
details of how the random sequence was generated, allocation and
blinding of outcomes were not provided. In addition, Bai 2004
did not provide a sample size calculation, nor was there clarifi-
cation of whether the target recruitment was reached to identify
statistically significant findings. Similarly, for the other four func-
tional scales there is no demonstrable evidence that psychosocial
intervention improves emotional functioning (MD 2.54, 95% CI
-4.81 to 9.89) (Figure 5; Analysis 1.2), social functioning (MD
-2.36, 95% CI -11.36 to 6.65) (Analysis 1.3), role functioning
(MD -1.43, 95% CI -7.31 to 4.46) (Analysis 1.4) or cognitive
functioning (MD -4.23, 95% CI -12.48 to 4.03) (Analysis 1.6) at
three to six months following psychosocial intervention. The anal-
ysis did not provide evidence for the effectiveness of psychosocial
intervention to improve global quality of life (MD -2.57, 95% CI
-13.54 to 8.40) (Analysis 1.5) at this time juncture.
Figure 4. Forest plot of comparison: 1 Intervention verus control, outcome: 1.3 EORTC QLQ C30 - Physical
function. Medium-term follow-up
Figure 5. Forest plot of comparison: 1 Intervention verus control, outcome: 1.6 EORTC QLQ C30 -
Emotional function. Medium-term follow-up.
End of intervention
Humphris 2012 and Katz 2004 did have data collection points
immediately at the end of intervention. Using end of interven-
tion data, these findings do show a small trend towards improved
cognitive function on the EORTC QLQ-C30 subscale immedi-
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ately following intervention (MD 2.78, 95% CI -4.82 to 10.37)
(Figure 6; Analysis 1.7) but this did not reach statistical signifi-
cance. This is an important result, suggesting that when head and
neck cancer patients’ anxieties and fears are addressed they are able
to demonstrate some improvement in their planning ability and
re-engage in their normal activities in the period immediately fol-
lowing intervention, although this effect is not maintained a few
months later. There was also a small trend towards improvement
in physical function at end of intervention (MD 6.74, 95% CI -
2.24 to 15.71) (Analysis 1.8) but this was not statistically signifi-
cant. There was no directional change in any of the other EORTC
QLQ-C30 subscales when exploring the effectiveness of the psy-
chosocial programmes at the end of intervention (Analysis 1.9;
Analysis 1.10; Analysis 1.11). There was no difference in global
quality of life between the two groups at this time point (Analysis
1.12).
Figure 6. Forest plot of comparison: 1 Intervention verus control, outcome: 1.9 EORTC QLQ C30 -
Cognitive function (end of intervention).
We performed no subgroup analyses according to theoretical ba-
sis or type of intervention, method of delivery (e.g. individual
versus group), discipline of professional delivering intervention
or duration of follow-up (i.e. short, medium, long-term) for the
primary outcome measure quality of life. Furthermore, the focus
of these interventions all varied. Katz 2004 used the format of a
brief, preparatory intervention timed immediately before surgery
for oral cancer.Humphris 2012 focused specifically on anxiety and
fear of recurrence in patients previously treated with surgery with
or without adjuvant therapies for oral and oropharyngeal cancer.
Bai 2004 combined cognitive behavioural therapy (CBT) and ex-
ercise therapy following treatment with radiotherapy for nasopha-
ryngeal cancer.
Brief narrative synthesis of studies not included in the
quality of life meta-analysis
The two remaining studies that reported onquality of life butwith-
out extractable data for meta-analysis were Fan 2006 and Yongqin
2009. Fan 2006 delivered a complex psychosocial intervention,
over a two-year duration. This intervention included not only a
psychological component based on CBT techniques and social
skills training but physical fitness training. This study did show
statistically significant improvements in mental state (MD 2.95,
95%CI 0.91 to 4.99, P < 0.05) and self evaluation of quality of life
(MD -0.6, 95% CI -1.22 to 0.16, P < 0.01) for the intervention
group. Akin to the other studies in this review, the reliability of
this finding remains limited due to the small sample sizes (n = 72)
but also due to the risk of bias for random sequence generation
and allocation concealment.
Yongqin 2009 focused their study on patients who had undergone
total laryngectomy, using a CBT approach and physical exercise to
promote mastery of managing physical and social situations and
promote quality of life over a two-year period. This intervention
did demonstrate a positive impact on the intervention group for
engaging with activities of daily living (MD 1.22, 95% CI 0.49 to
1.95, P = 0.001) and recreation (MD 1.5, 95% CI 0.88 to 2.16, P
= 0.00001) at the end of intervention. The authors have provided
limited information on study design, thus the risk of bias remains
somewhat unclear for this study.
Anxiety
Effects on anxiety were measured in three studies (Allison 2012;
Humphris 2012; Katz 2004) and data were extractable from these
studies for inclusion in a meta-analysis. In Allison 2012 and
Humphris 2012 anxiety was measured using the Hospital Anxiety
and Depression Scale (HADS), commonly used in cancer popu-
lations. These studies both report anxiety scores at three to four
months post-intervention (medium-term follow-up). The remain-
ing study (Katz 2004) also used a validated tool but one that is
not as widely reported in the cancer literature, namely the State-
Trait Anxiety Inventory. This tool has two subscales as its name
suggests, one for state anxiety and the other for trait anxiety. The
state anxiety score at threemonths post-intervention has been used
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in this meta-analysis. Analysis 1.13 shows that the overall effect
size is not statistically significant (standardised mean difference
(SMD) -0.09, 95% CI -0.40 to 0.23). Heterogeneity was low (I
2 = 0%). This finding is replicated at end of intervention (SMD
-0.09, 95% CI -0.41 to 0.23) with low heterogeneity (I2 = 0%)
(Analysis 1.14).
Depression
We produced a combined analysis of results across four studies (n
= 335) that represent depression using validated measures (Allison
2012; Duffy 2006; Humphris 2012; Katz 2004). Three different
tools were used to measure depression (see Included studies, sub-
section on outcomemeasures). These four studies all measured de-
pression at three to six months post-intervention (medium-term
follow-up). The analysis did not provide evidence of the effective-
ness of psychosocial intervention to alleviate depression amongst
patients who had treatment for head and neck cancer. The effect
size was not significant (SMD -0.00, 95% CI -0.22 to 0.21) at
end of intervention (Analysis 1.16) or at medium-term follow-up
(SMD -0.03, 95% CI -0.24 to 0.19) (Analysis 1.15), with low
statistical heterogeneity in the outputs of pooled estimates (I2 =
0%).
The four studies that reported on the effectiveness of psychosocial
intervention to alleviate distress (anxiety and depression) all had
extractable data for medium-term follow-up. Nonetheless, as the
specific focus of the intervention varied between the studies, from
preparation before and directly after surgery (Katz 2004) to fear of
recurrence (Humphris 2012) (as noted above in the quality of life
section), thismay, in part, have contributed to the inconclusiveness
as to the effectiveness of psychosocial intervention for patients
with head and neck cancer.
Other secondary outcome measures
Brief narrative synthesis of studies with additional secondary
outcome measures not suitable for meta analyses
In addition to assessing the effectiveness of their psychoeduca-
tional intervention for reducing anxiety and depression (see find-
ings above), in Allison 2012 testing took place for the following
two secondary outcomes measures: self esteem and coping. The
respective validated tools were used: the Rosenberg Self-Esteem
scale (Rosenberg 1965) and Ways of Coping Checklist (Folkman
1980). The Ways of Coping Checklist assesses thoughts and ac-
tions used to cope with stressful cancer-related events. It measures
coping processes, rather than coping dispositions or styles. The
findings demonstrate that both the intervention group and the
attention-placebo (control) group had improved self esteem and
coping. Therefore, the results suggest that patients receiving the
psychosocial intervention therapy had no improvements in self
esteem and coping beyond those noted in the placebo group, who
had one to three meetings where they could discuss cancer-related
issues of their choice with information provided on support ser-
vices.
The intervention used in the Humphris 2012 study is described
in detail in a previous publication (Humphris 2008). The Adjust-
ment to the Fears, Threat andExpectationofRecurrence (AFTER)
intervention programme included assessing worry using the three-
item Worry of Cancer Scale (Easterling 1989) and adjustment
to cancer using the 40-item Mental Adjustment to Cancer Scale
(Watson 1989). Fear of recurrence as assessed using the Worry of
Cancer Scale did improve significantly in the intervention group
as opposed to the control group at the end of intervention (effect
size = 0.5). Similarly, the anxious preoccupation subscale on the
Mental Adjustment to Cancer Scale demonstrated a significant
difference at the end of intervention (effect size = 0.7), but this was
not sustained at four months post-intervention. A small, positive,
indirect effect of the intervention was found using a structured
equation analysis for theWorry of Cancer Scale at fourmonths fol-
low-up. However, no significant changes were noted on the fight-
ing spirit and hopelessness subscales of the Mental Adjustment
to Cancer Scale at immediate or medium-term follow-up in the
intervention group relative to those receiving standard care.
In Katz 2004 the focus of the psychoeducational intervention was
to facilitate preparation for newly diagnosed oral cancer pending
surgical treatment and to promote coping with the consequences
of invasive surgery. In this pilot study, totaling 19 participants,
Katz 2004 used an assessment package with 11 different tools
(see Characteristics of included studies). As well as reporting on
quality of life and psychological distress (see above), the follow-
ing secondary outcome measures were assessed: social function-
ing, adjustment to cancer, body image, self efficacy and life satis-
faction. These pilot data revealed that the intervention group had
higher satisfaction with their appearance at three months follow-
up compared to the control group. No evidence of effectiveness
was demonstrated on any of the remaining secondary outcome
measures. Caution must be used in interpreting these findings,
given the small sample size with multiple analyses from the large
battery of questionnaires used. Furthermore, there is no mention
of a counter-balancing technique being used, which randomises
the order of the questionnaires, to control for fatigue effects when
using a large number of questionnaires.
D I S C U S S I O N
Summary of main results
This review includes seven randomised controlled trials (RCTs),
totaling 542 participants, denoting a paucity of research evaluat-
ing psychosocial interventions for head and neck cancer patients.
From these studies, there is no evidence that psychosocial inter-
vention promotes global quality of life for patients with head and
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neck cancer. The analysis did not provide evidence to support any
improvement of physical, role, cognitive, emotional or social func-
tioning by psychosocial intervention. Also, from the limited data
available, there were no demonstrable changes in levels of anxiety
or depression following intervention for patients with head and
neck cancer.
RCTs in this review had notable variations in the focus of the in-
tervention, ranging from preparation for post-surgical changes to
dealing with fear of recurrence. Sometimes the intervention de-
scribed in the seven studies overlapped in the theoretical premise
to include aspects of cognitive behavioural therapy and psychoed-
ucation. Heterogeneity was also present when the mode of inter-
vention delivery and assessment tools were considered. Given this
high level of variation, we have not conducted further subgroup
analysis. In this review we could not determine the optimal du-
ration (number of sessions) or intensity (regularity of sessions) of
therapy or whowas best placed to facilitate such interventions (e.g.
nurse, psychologist). In light of this, it is challenging to present a
clear statement about effectiveness, as currently there is a lack of
convincing evidence to support universal implementation of psy-
chosocial interventions to improve quality of life or reduce psy-
chosocial distress. In conclusion, much remains to be done before
firm evidence on the effects of psychosocial intervention for pa-
tients with head and neck cancer is available.
Overall completeness and applicability of
evidence
There is a lack of generalisability of the evidence from this review.
This is due to the limited number of studies with small sample
sizes, reporting on different categories of psychosocial interven-
tion and using a wide range of outcome measures. As previously
noted, there was only sufficient evidence to pool the results for
the primary outcome, namely quality of life, and for two sec-
ondary outcomes, anxiety and depression. Furthermore, not all
the studies had extractable data for these outcomes. For example,
the main statistical finding of this review is based on quality of
life data, with extractable data from only 26% (141 out of 542) of
the participants recruited, totaling three out of the seven included
studies. The statistical analysis of depression represented a greater
number of the overall participants in this review (62%, 335 out
of 542 participants), whereas the anxiety outcome measure only
represents data pooled from 29% of the overall participants (157
out of 542 participants). There were insufficient data to address
the remainder of the secondary outcomes in meta-analyses in this
review, such as coping, social functioning, self esteem, self efficacy,
body image, locus of control, adjustment/adaptation, life satisfac-
tion and satisfaction with the intervention.
This review has highlighted a wide range of psychosocial inter-
ventions, which have been developed to promote quality of life
and reduce distress following treatment for head and neck can-
cer. However, the importance of diversity must be recognised, in
that there is a universal understanding that facilitation of post-
treatment coping may not be met by ’a one size fits all’ approach.
Counter-balancing this, the wide divergence in this small number
of RCTs with small samples limits conclusive evidence on which
type or what aspects of the intervention are most applicable.
There was also considerable disparity in what constituted the con-
trol group for each study. AlthoughBai 2004, Fan 2006,Humphris
2012,Katz 2004 andYongqin 2009 all report usual care, themodel
of care can vary considerably between countries. On the other
hand, Allison 2012 had an attention placebo as the control group,
which allowed participants to discuss cancer-related issues and to
be informed of available support services. Similarly, Duffy 2006
used enhanced usual care, to include referral to targeted support
services and a handout of relevant resources. Interestingly, neither
of these studies (Allison 2012; Duffy 2006) with enhanced usual
care demonstrated any significant improvement in anxiety or de-
pression compared to the experimental arm.
A further disparity that must be acknowledged is that Allison 2012
and Duffy 2006 screened for psychosocial distress prior to accrual,
whereas this was not undertaken by the other studies. We would
advocate amechanism of screening for a pre-identified need for the
targeted intervention. This would not only mirror clinical practice
but encourage best utilisation of resources.
Regarding the applicability of the evidence, it is important to note
that three out of seven studies were conducted in China (Bai
2004; Fan 2006; Yongqin 2009) and this may be considered as
a limitation to the generalisability of the results because of the
differing cultural context of health and well-being. These three
studies had no participants lost to follow-up.
The longest period of follow-up after completion of the interven-
tion was six months (Duffy 2006). The remaining studies (Allison
2012; Bai 2004; Fan 2006; Humphris 2012; Katz 2004; Yongqin
2009) varied between three and four months. Therefore, the con-
clusions drawn from this review are only applicable for short and
medium-term follow-up, with no evidence available for long-term
follow-up.
Quality of the evidence
We rated only one study included in this review as being at an en-
tirely low risk of bias (Allison 2012). The lack of important details
on a number of the criteria in the other six studies (Bai 2004;Duffy
2006; Fan 2006; Humphris 2012; Katz 2004; Yongqin 2009) pre-
cluded an adequate assessment of their quality. Therefore, to em-
ploy a more robust judgement on the quality of the evidence, it
is important for authors to provide clear, specific and relevant de-
tail, especially on their method of participant selection. Figure 2
demonstrates that the overall risk of bias for four out of the seven
studies is over 50%. The blinding of participants to group alloca-
tion in such studies is especially challenging and inmany instances
may not be possible. Nonetheless, studies should introduce blind-
ing of outcome assessment as a prerequisite. Blinding of outcome
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assessors was reported by Allison 2012, Fan 2006,Humphris 2012
and Katz 2004.
Other indicators of quality include power calculations to guide
sample size. Only two studies (Allison 2012; Humphris 2012)
report clearly that a power calculation was conducted, however the
sample size requiredwas not achieved in either study. Furthermore,
many of the other included studies could be considered as under-
powered to detect statistical differences between the experimental
and control group.
A CONSORT flow chart was only present in two of the included
studies (Allison 2012; Humphris 2012). Important information
can be gleaned easily from these flowcharts, including poor accrual
to such trials in this patient population. Allison 2012 highlights
that 32% of participants approached to participate in the study
refused to do so, leading to a concern regarding recruitment bias.
The challenge of accrual of head and neck cancer patients to trials
is a well-known phenomenon. A similar trend was reported by
Duffy 2006, in that of the 439 eligible patients, 255 were not
randomised due to refusal (n = 179) or inability to contact (n =
76). Therefore, 42% of those eligible were recruited to this trial.
With the exception of the three Chinese studies and the small
pilot study by Katz 2004, attrition rates from the other trials were
relatively high, varying between 14% and 30% (Allison 2012 =
30%, Duffy 2006 = 17%, Humphris 2012 = 14%).
The three studies conducted in China (Bai 2004; Fan 2006;
Yongqin 2009) had their findings reported in Chinese and re-
quired translation. Data extraction forms were completed by one
translator who was an author from the Cochrane ENT Disorder
Group. Therefore, quality checks on data extraction from these
three translated studies were not performed independently by a
member of this review group.
Potential biases in the review process
This review took an inclusive approach to the term psychosocial
intervention. Such a broad approach may have introduced hetero-
geneity, but it also led to a large number of references (n = 1035)
being retrieved from the search, presenting the challenge of assess-
ing and assimilating the evidence for relevant studies (n = 7). Due
to the large number of references retrieved from the search for this
patient population, we excluded grey literature such as disserta-
tion theses and conference and poster abstracts. This again could
introduce a degree of publication bias.
Some of the studies initially retrieved had mixed patient popula-
tions, including head and neck cancer survivors. Given that none
of these studies had conducted subgroup analysis on patients with
head and neck cancer, or following personal contact with the au-
thors such data were not available, this review was limited to trials
that solely recruited patients with head and neck cancer.
All the steps in the review process were conducted by two review
authors (except for the data extraction forms for the three Chinese
studies mentioned earlier). When necessary a third review author
was consulted. Data input and analysis were carried out by the
first author (CS) and checked by a second author (AN).
Agreements and disagreements with other
studies or reviews
We identified one relevant systematic review (Luckett 2011). This
systematic review included nine studies, of which two were RCTs,
five were case controlled studies, one study was a pre-test post-test
design and one study was post-test only with controls. No meta-
analysis was conducted due to the heterogeneity in the type of
interventions and outcome measures used. Based on a narrative
synthesis, Luckett 2011 reported that there was some evidence for
psychosocial interventions, with six out of the nine studies report-
ing at least one statistically significant benefit for the intervention
versus control group. However, no studies found significant effects
across all outcomes. In conclusion, Luckett 2011 provides a similar
conclusion to this Cochrane review. In other words, the evidence
for psychosocial intervention is limited due to the small number
of studies, diversity of interventions evaluated and shortcomings
in study designs and reporting.
Within the literature there is one further relevant descriptive re-
view byHowren 2012. They appraised the evidence on several psy-
chosocial and behavioural factors associated with head and neck
cancer and included various psychosocial interventions. They con-
cluded that several of the interventions appeared promising. How-
ever, they also noted that more rigorous and thorough testing is
necessary given the lack of RCTs and the inherent methodolog-
ical flaws in the small number of available studies. Furthermore,
they highlighted the low accrual rates even for the briefest, least
burdensome interventions.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review suggests that currently there is insufficient evidence to
refute or support the effectiveness of psychosocial interventions for
patients with head and neck cancer. This review was also unable
to provide any evidence to support any specific type of psychoso-
cial intervention for patients treated with head and neck cancer,
in relation to theoretical perspective, duration, setting, mode of
delivery or intensity.
Patients should be screened to target those at greatest risk of psy-
chosocial difficulties, as currently there is no evidence to suggest a
universal application of psychosocial intervention for all patients.
The use of a tiered intervention approach in response to risk screen-
ing at key junctures in the cancer journey is recommended by the
UK National Institute for Clinical Excellence (NICE) guidelines
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(NICE 2004) and the international guidelines for psycho-oncol-
ogy (Coleman 2011).
Implications for research
Due to the small number of studies, which are generally not of
high quality, the main conclusion of this review relates to how
future research in this area should be conducted. There is a clear
need for future intervention trials, but the ongoing challenge with
conducting such studies is the relatively small number of patients
available for accrual at any one cancer centre. To overcome this, a
collaborative, multi-centred approach will be necessary. Further-
more, there is a need for a consensus on what type of intervention
and delivery approach is most effective. Appraisal of the broader
cancer literature to include systematic reviews on general or other
site-specific cancer populations could help inform intervention
design. It is important that interventions used in other cancer pop-
ulations are modified for head and neck cancer patients, given the
unique needs of this patient group, followed by further feasibil-
ity testing, prior to conducting larger randomised controlled trials
(RCTs). Planning of such RCTs should include a power calcula-
tion to ensure adequate sample sizes, which will facilitate planning
for recruitment.
There is a need for uniformity in outcome measures used to eval-
uate psychosocial interventions in head and neck cancer, thus en-
abling future meta-analyses to be conducted. Preference should be
given to the European Organisation for Research and Treatment
of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) as
a measure of quality of life. Modification of such validated mea-
sures must be discouraged as this again prevents data entry into
meta-analyses.
There is currently much debate over which screening measure is
most appropriate for anxiety and depression. Coyne and van Son-
derena have heavily criticised the Hospital Anxiety and Depres-
sion Scale (HADS) for its psychometric qualities and suggest using
other measures with cancer patients (Coyne 2012). This editorial
was in response to the critical review of the factorial structure that
has recently appeared in the literature (Cosco2012). Subsequently,
a comment by Doyle 2012 has pointed to a need for caution in
the abandonment of the HADS, as it can still be useful to assess
general distress. This is supported by Norton 2012. In addition,
Norton and colleagues have conducted a strenuous meta-analysis
of the HADS and found that although the factorial structure is
not as clear as the originators of the scale suggested (two factors
of depression and anxiety) the scale does behave quite consistently
when a general distress factor is included - hence a three-factor
model (Norton 2013).
Other outcome measures worth noting are the Patient Health
Questionnaire (PHQ-9) (Kroenke 2001) and the Generalised
AnxietyDisorder seven-item scale (GAD-7) (Spitzer 2006) asmea-
sures for assessing general distress symptomology. The PHQ-9 is a
short, easy to use depressionmodule, which scores each of the nine
Diagnostic and Statistical Manual ofMental Disorders (DSM-IV)
criteria. Validity has been assessed against an independent, struc-
tured mental health professional interview. A PHQ-9 score ≥ 10
had a sensitivity of 88% and a specificity of 88% for major depres-
sion (Kroenke 2001) and is worth considering as an outcomemea-
sure for depression in future studies. Whichever scale is deployed
in research studies, there is an ongoing search for understanding
of the construct validity and interpretation of the scores across age
and demographic groups (Cameron 2012).
Consideration should also be given to the screening of individ-
uals prior to recruitment. For example, if the premise of the in-
tervention is to reduce fear of recurrence, participants should be
screened using a suitably validated tool for this construct as part of
the eligibility process, prior to accrual. This approach to eligibil-
ity according to an identified need is advocated and would avoid
’floor effects’ of those with no expressed need, thus diluting the
observed effects of psychosocial interventions. Mitchell 2012 also
states that intervention programmes will have limited effect unless
identified cases receive treatment which alters outcomes.
Anothermajor consideration for future researcherswithin this field
is the reporting of the findings. In order for RCTs to be appraised
they should include detailed information about the intervention
and its underlying theoretical premise. It is also necessary to de-
scribe the intervention setting, who delivered the intervention, its
frequency and its intensity. In this field of psychosocial research it
is particularly important that researchers are reminded that when
publishing they provide sufficient information on method of ran-
domisation, blinding etc., therefore allowing readers to make a
judgement on the quality of the evidence. Also, due to the cur-
rent financial constraints faced by many healthcare systems, there
is an overwhelming need to involve health economists, to assess
whether such interventions have cost benefits for providers of care
to head and neck cancer survivors. In conclusion, there is a need
for RCTs that are powered correctly, theoretically derived and have
good endpoints and validated outcome.
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Gender: male 61% (n = 37), female 39% (n = 24)
• Diagnosed with primary cancer of the head and neck region
• Screened for psychological distress prior to accrual and defined by scoring > 7 on
the anxiety and/or depression scale of the Hospital Anxiety and Depression Scale
(HADS)
Excluded if undergoing palliative or terminal care, had previous history of malignancy
affecting other parts of the body, diagnosed with depression and currently undergoing
any antidepressive therapy or living beyond 90 minutes travelling time by car/taxi from
recruitment site or unwilling to travel to recruitment hospital for intervention
Interventions Intervention group:
Description: psychoeducational programme consisting of problem-solving, relaxation
techniques, cognitive coping skills, goal setting, communication social support and
lifestyle factors
Duration: 2 or 3, 1 to 2-hour sessions over a 4-week period. Provided with manual, plus
audio material containing verbal instructions and music for relaxation section in CD or
cassette
Delivered by trained therapists
Control group:
Description: attention placebo allowing participant to discuss cancer-related issues of
their choice and informed of support services available at recruitment site (hospital) or
local community services
Duration: 1 to 3, 1 to 2-hour sessions over a 4-week period
Delivered by trained therapist (same therapist as intervention group)
Outcomes Baseline and 4 months post-randomisation
• Depression - HADS
• Coping - Ways of Coping Checklist
• Personality (optimism/pessimism) - Life Orientation Test
• Self esteem - Rosenberg Self-Esteem scale
Notes Supported by Canadian Institutes of Health Research award MCT-75475
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation list
used
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Allison 2012 (Continued)
Allocation concealment (selection bias) Low risk Generation of allocation sequence was per-
formed at a distant site by an individ-
ual who was otherwise independent of the
project
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “The study subjects were kept
blinded to their receiving the test or placebo
control interventions”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Blinding was also used for the re-
search assistant who collected the data”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data clearly accounted for
Selective reporting (reporting bias) Low risk All outcome data reported






Gender: male 58% (n = 26), female 42% (n = 19)
• Diagnosed with nasopharyngeal carcinoma
• Karnofsky Performance Status (KPS) > 60
• Received radical course of radiotherapy
• No evidence of distant metastasis
• No other chronic disease
Interventions Intervention group:
Description: cognitive behaviour therapy and exercise (kinesiatric) intervention. Psy-
chosocial component provided information on treatment, prognosis, cure and rehabil-
itation to include clarification of mistaken cognitions. Participants were encouraged to
develop coping methods to include new life values, reduce tension and depression, es-
tablish positive life attitude and set hope for the future. Relaxation training and exercise





Outcomes Assessed at 3 months after radiotherapy
• Quality of life - EORTC QLQ C30:
Physical function, role function, social function, emotional function, cognitive function,
24Psychosocial interventions for patients with head and neck cancer (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bai 2004 (Continued)
general quality of life and 3 symptom items (fatigue, pain, nausea and vomiting)
Notes Paper in Chinese and completion of data extraction form was arranged by editorial staff
at Cochrane ENT Disorders Group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised quoted in text; no description given of se-
quence generation
Allocation concealment (selection bias) Unclear risk Inadequate information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not mentioned
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Quote: “the first and second authors and rehabilitative
physicians worked together to accomplish outcome assess-
ment”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants lost to follow-up
Selective reporting (reporting bias) Low risk All outcome data reported
Other bias Low risk None identified
Duffy 2006
Methods Multi-centred RCT
Conducted in United States
Participants 184 participants
Age: mean 57
Gender: male 84% (n = 155), female 16% (n = 29)
• Screened positive for one or more of the following: smoking, alcohol use and
depression
• Not pregnant
Excluded if non-English speaking, distant metastatic disease and/or were terminal and
unstable psychiatric/mental conditions such as suicidal ideation, acute psychosis, severe
alcohol dependence or dementia
Interventions Intervention group:
Description: CBT delivered by telephone and workbook with pharmacologic interven-
tion, if required. CBT approaches emphasised goal-setting, self monitoring, analysed
behavioural antecedents, coping skills and social skills training. CBT sessions, workbook
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Duffy 2006 (Continued)
and pharmacologic interventions were tailored depending on health problem (smoking,
alcohol use and depression). CBT workbook had 4 sections: core section, tobacco tactics,
drinking decisions and mood management
Duration: 45-minute nursing assessment and brief counselling, followed by 9 to 11
telephone sessions of CBT
Delivered by nurses trained in CBT and supporting patients with tobacco and alcohol
problems
Control group:
Description: enhanced usual care. Participants were referred as needed for smoking
cessation and/or alcohol treatment and/or psychiatric evaluation. Participants received a
handout for local, state and national resources
Duration: 45-minute nursing assessment and brief counselling
Delivered by nurse
Outcomes Baseline and 6 months post-intervention
• Smoking status (no tool)
• Alcohol use: Alcohol Use Disorder Identification Test (AUDIT)
• Depression: Geriatric Depression Scale-Short Form
Notes Funding from theDepartment of Veterans Affairs IIR98-500, GlaxoSmithKline through
the Managed Care Forum and the NIH through the University of Michigan’s Head and
Neck Specialized Programs for Research Excellence grant 1P50 CA97248
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised quoted in text; no description
given of sequence generation
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not mentioned
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not mentioned
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data accounted for
Selective reporting (reporting bias) High risk Only dichotomous data reported for AU-
DIT and CES-D scales
Other bias High risk Funding from GlaxoSmithKline who pro-
duce both nicotine patch and bupropion
which are part of the pharmacologic man-
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Duffy 2006 (Continued)








• Diagnosed with nasopharyngeal carcinoma
Excluded if in terminal phase of illness, history of mental illness or could not understand
the content of the questionnaires
Interventions Intervention group:
Description: systematic mass anticancer education over a 2-year period focusing on body
function, mental well-being and social reintegration. The 3 components encompassed:
1) physical function rehabilitation - lecture on the pathogenic mechanism, treatment,
follow-up and prognosis of nasopharyngeal carcinoma, and regular lectures on rehabili-
tation and exercise training; 2) mental well-being - lecture on mental health and group
activities on cognitive psychological techniques; 3) social reintegration - small group
activities exchanging roles, reassessing responsibilities of society and family, and class on
health education and rehabilitation
Duration: 2 years
Physicians, nurses and medical students were trained to deliver the intervention
Control group:
Usual care
Outcomes Baseline and following the intervention (duration of intervention: 2 years)
• Quality of life - the statistical survey table of vital quality of patients with
carcinoma of the healing stage, designed after the EORTC QLQ-C30 with the
following subscales:
Physical function, mental health, social function, general quality of life, symptom and
side effects and special side effects
Notes Supported by the Basic Research Program of Application in Sichuan Province, No.
01SY051-46
Paper in Chinese and data extraction was arranged by editorial staff at the Cochrane
ENT Disorders Group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised quoted in text; no description given of se-
quence generation
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Fan 2006 (Continued)
Allocation concealment (selection bias) Unclear risk Inadequate information
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not mentioned
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “double-blind investigation was conducted on pa-
tients by investigators”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants lost to follow-up
Selective reporting (reporting bias) Low risk All outcome data reported
Other bias Unclear risk None identified
Humphris 2012
Methods RCT
Conducted in United Kingdom
Participants 77 participants (87 participants randomised, 10 lost to follow-up)
Age: mean 59
Gender: male 71%, female 29%
• Diagnosed with primary orofacial cancer
• Age range of 18 to 75 years
Excluded if psychotic, threatened to commit suicide or severe intellectual deficit
Interventions Intervention group:
Description - time-limited, theory driven, structured, individualised psychological in-
tervention based on a cognitive behavioural model of self regulation to address fears of
recurrence. Patient is assessed at first session and intervention tailored. Invited to explore
illness belief and behaviours. Relaxation practised in sessions. Caregivers can be incor-
porated in programme if desired by patient
Duration - 6 weekly sessions. Length of each intervention session = 30 to 50 minutes
Delivered by trained specialist nurse who followed a standardised manual (AFTER -
adjustment to fears, threats and expectation of recurrence)
Control group:
Usual care
Outcomes Data collected 3, 7, 11 and 15 months following treatment. Intervention was delivered
during the interval between 7 and 11-month assessment. Baseline was considered as 7
months, end of intervention as 11 months and 14 months as 4months post-intervention
• Depression - HADS
• Worry - Worry of Cancer Scale (WOC)
• Adjustment to cancer - Mental Adjustment to Cancer Scale
• Quality of life - EORTC QLQ-C30 v 2, which consists of 5 functional scales
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Humphris 2012 (Continued)
(physical, role, cognitive, emotional and social), a separate global quality of life scale
and 3 symptom scales (fatigue, pain and nausea and vomiting)
• Disease-specific quality of life - EORTC QLQ H&N35
Notes Supported by CR-UK CP1031/0102
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “computer-generated random number
sequence”
Allocation concealment (selection bias) Low risk Quote: “she subsequently made contact with
the study administrator who picked the next
numbered envelope from the computer-gener-
ated random number sequence (independently
prepared by the faculty statistician)”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Insufficient information
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “assessor was blind to group assign-
ment”, “post-intervention data blind to thera-
pist”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 10 patients lost to follow-up and rationale given
in section “adherence to study design”
Selective reporting (reporting bias) Unclear risk Narrative only on quality of life data
Other bias Unclear risk Following randomisation 5 participants in the
intervention group declined intervention but
outcome data included and remain as part of






Gender: male 63% (n = 14), female 37% (n = 5)
• Newly diagnosed, untreated oral cavity cancer
• Proposed curative surgical treatment
• Absence of significant cognitive impairment
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Katz 2004 (Continued)
• Minimum of Grade 8 education
Interventions Intervention group:
Description: psychoeducational intervention delivered in verbal and written format.
The psychoeducational booklet (95 pages) was disseminated in 2 parts: a) preparing
for surgery and the postoperative course and b) preparing for your return home. This
booklet covered information about oral cancer and its treatment and effective coping
strategies. The content was presented by a research nurse and patients were encouraged
to ask questions and express concerns
Duration: 2 brief supportive contacts (60 to 90 minutes). First supportive contact was
pre-operatively, via telephone. Second supportive contact was postoperatively, via face-
to-face contact
Delivered by a research nurse
Control group:
Usual care
Outcomes Baseline (pre-operative) and 3-months post-discharge
Knowledge questionnaire
Disfigurement: Observer-Rated Disfigurement Scale
Alcohol use: SMAST-13 Alcoholism
Social Support: MOS Social Support Survey (perceived social support)
Recent stressful life events (composite checklist)
Self efficacy: Stanford Inventory of Cancer Patients Adjustment (SICPA)
Anxiety: State-Trait Anxiety Inventory (STAI)
Depression: Center for Epidemiologic Studies-Depression scale (CES-D)
Well-being: Affect Balance Scale
Life satisfaction: Atkinson Life Happiness Rating Scale
Illness intrusiveness: Illness Intrusiveness Rating Scale
Quality of life: EORTC QLQ-C30
Body image (unpublished by authors)
Notes Funded by National Cancer Institute of Cancer (grant #007096)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Random numbers table”
Allocation concealment (selection bias) Unclear risk No detail provided
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants or personnel delivering interven-
tion not mentioned. Only reference to the research nurse
delivering the intervention being blind to the results of
all assessments
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Katz 2004 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “The study assessment packages were adminis-
tered by the research coordinator who was not involved
in the delivery of the intervention”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants lost to follow-up
Selective reporting (reporting bias) Low risk All outcome data reported






Gender: male 84.5% (n = 71), female 15.5% (n = 13)
• Biopsy proven laryngeal or hypopharyngeal carcinoma
• Having undergone a laryngectomy
Excluded if diagnosed with a second cancer following laryngectomy, had local or distant
metastasis 6 months after surgery, lack of follow-up data (more than 50%) or failed to
attend follow-up
Interventions Intervention group:
Description: CBT. Cognitive therapy included understanding the cancer, learning how
to cope and ensuring the patients had social support. Behavioural therapy included new
ways of communication, self management of stoma and patients were encouraged to
take part in group activity, recreation and sports but maintain balance between rest and





Outcomes Baseline and following the intervention (duration of intervention 2 years)
Quality of life: the quality of life table forWashington medical college students - Chinese
version (v 2) with the following subscales: pain, appearance, instrumental activities of
daily living, recreation, work, chew, swallow, speaking and communication and shoulder
function
Notes Paper in Chinese and data extraction was arranged by editorial staff at the Cochrane
ENT Disorders Group
Risk of bias
Bias Authors’ judgement Support for judgement
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Yongqin 2009 (Continued)
Random sequence generation (selection
bias)
Unclear risk Randomised quoted in text; no description given of se-
quence generation
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not mentioned
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not mentioned
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants reported as lost to follow-up
Selective reporting (reporting bias) Low risk All outcome data reported
AUDIT: Alcohol Use Disorder Identification Test
CBT: cognitive behavioural therapy
CES-D: Centre for Epidemiologic Studies Depression Scale
EORTC: European Organisation for Research and Treatment of Cancer
ENT: ear, nose and throat
HADS: Hospital Anxiety and Depression Scale
NIH: National Institutes of Health
QLQ: Quality of Life Questionnaire
RCT: randomised controlled trial
Characteristics of excluded studies [ordered by study ID]




Included patients with head and neck cancer
INTERVENTION
Patients received psychological communication training
OUTCOMES
Did not use a validated outcome measure
Fiegenbaum 1981 ALLOCATION
Not randomised
32Psychosocial interventions for patients with head and neck cancer (Review)







Included patients with head and neck cancer
INTERVENTION
No face-to-face contact. Focus was symptom control and not a psychosocial intervention
OUTCOMES




Included patients with head and neck cancer. No separate subgroup analysis for patients with head and neck








Included patients with head and neck cancer
INTERVENTION
Patients received psychosocial intervention - individualised counselling
OUTCOMES
Personality Trait Inventory - not predefined primary or secondary outcome measure
Vakharia 2007 ALLOCATION
Not randomised
van den Brink 2007 ALLOCATION
Not randomised - quasi-experimental design (based on hospital location)
PARTICIPANTS
Included patients with head and neck cancer
INTERVENTION
Electronic health information - no face-to-face contact
Vilela 2006 ALLOCATION
Not randomised
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Characteristics of ongoing studies [ordered by study ID]
de Leeuw
Trial name or title The effect of comprehensive counselling by a nurse specialist on depressive symptoms and quality of life: a
prospective randomised study in patients with head and neck cancer
Methods RCT, parallel group
Participants 154 (target number)
Interventions Comprehensive counselling by a nurse specialist to help the patient deal with physical symptoms and impair-
ments, to reduce emotional distress and improve morale, coping and sense of control
6 sessions over a 1-year period
Outcomes CES-D, EORTC QLQ-C30, EORTC QLQ-HN35, Worry of Cancer Scale, Uncertainty in Illness Scale
Starting date Dec 2003
Contact information Dr JRL de Leeuw
Notes Recruitment is possibly completed. Additional information sought but not obtained on trial status
Kangas
Trial name or title Treatment of anxiety and depression in head and neck cancer patients
Methods RCT, parallel group
Participants 160 (target number)
Interventions CBT comprising relaxation, stress management and coping skills training
6 weekly sessions, face-to-face during radiotherapy and a booster session of CBT 1 month following comple-
tion of radiotherapy
Outcomes Clinician Administered PTSD Scale, Beck Depression Inventory, STAI, FACT, Brief COPE, treatment cred-
ibility scale to assess individuals’ beliefs about treatment efficacy
Starting date April 2007
Contact information Dr Maria Kangas
Notes Recruitment is possibly completed. Additional information sought from primary author but not obtained on
trial status
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Verdonck-de Leeuw
Trial name or title Cost-effectiveness of a stepped care strategy to improve symptoms of depression or anxiety in patients treated
for head and neck cancer or lung cancer
Methods RCT, parallel group
Participants 176 (target number)
Interventions Stepped care model with 4 evidence-based steps: 1) watchful waiting, 2) internet-based self help, 3) problem-
solving therapy applied by a nurse, 4) specialised psychological intervention and/or antidepressant medication
Control group: usual care
Outcomes HADS, EORTC QLQ-C30, EORTC QLQ-HN35, EORTC QLQ-LC13, EORTC QLQ-PATSAT, health
care utilisation and work loss (TIC-P and PRODISQ modules)
Starting date June 2009
Contact information Dr IM Verdonck-de Leeuw
Notes
CBT: cognitive behavioural therapy
CES-D: Centre for Epidemiologic Studies Depression Scale
EORTC: European Organisation for Research and Treatment of Cancer
FACT: Functional Assessment of Cancer Therapy
HADS: Hospital Anxiety and Depression Scale
PATSAT: patient satisfaction with care
PTSD: Post-Traumatic Stress Disorder
QLQ: Quality of Life Questionnaire
RCT: randomised controlled trial
STAI: State-Trait Anxiety Inventory
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D A T A A N D A N A L Y S E S
Comparison 1. Intervention versus control




participants Statistical method Effect size
1 EORTC QLQ C30 - Physical
function (medium-term
follow-up)
3 138 Mean Difference (IV, Random, 95% CI) 6.28 [-10.05, 22.60]
2 EORTC QLQ C30 - Emotional
function (medium-term
follow-up)
3 138 Mean Difference (IV, Random, 95% CI) 2.54 [-4.81, 9.89]
3 EORTC QLQ C30 - Social
function (medium-term
follow-up)
3 138 Mean Difference (IV, Random, 95% CI) -2.36 [-11.36, 6.65]
4 EORTC QLQ C30 - Role
function (medium-term
follow-up)
3 138 Mean Difference (IV, Random, 95% CI) -1.43 [-7.31, 4.46]
5 EORTC QLQ C30 - Global
quality of life (medium-term
follow-up)
3 138 Mean Difference (IV, Random, 95% CI) -2.57 [-13.54, 8.40]
6 EORTC QLQ C30 - Cognitive
function (medium-term
follow-up)
3 138 Mean Difference (IV, Random, 95% CI) -4.23 [-12.48, 4.03]
7 EORTC QLQ C30 - Cognitive
function (end of intervention)
3 141 Mean Difference (IV, Random, 95% CI) 2.78 [-4.82, 10.37]
8 EORTC QLQ C30 - Physical
function (end of intervention)
3 141 Mean Difference (IV, Random, 95% CI) 6.74 [-2.24, 15.71]
9 EORTC QLQ C30 - Emotional
function (end of intervention)
3 141 Mean Difference (IV, Random, 95% CI) 4.15 [-3.60, 11.89]
10 EORTC QLQ C30 - Social
function (end of intervention)
3 141 Mean Difference (IV, Random, 95% CI) -3.03 [-12.04, 5.98]
11 EORTC QLQ C30 - Role
function (end of intervention)
3 141 Mean Difference (IV, Random, 95% CI) 1.31 [-4.85, 7.47]
12 EORTC QLQ C30 -
Global quality of life (end of
intervention)
3 141 Mean Difference (IV, Random, 95% CI) 1.23 [-5.82, 8.27]
13 Anxiety (medium-term
follow-up 3 to 4 months)
3 157 Std. Mean Difference (IV, Random, 95% CI) -0.09 [-0.40, 0.23]
14 Anxiety (end of intervention) 3 157 Std. Mean Difference (IV, Random, 95% CI) -0.09 [-0.41, 0.23]
15 Depression (medium term
follow-up 3 to 6 months)
4 335 Std. Mean Difference (IV, Random, 95% CI) -0.03 [-0.24, 0.19]
16 Depression (end of
intervention)
4 335 Std. Mean Difference (IV, Random, 95% CI) -0.00 [-0.22, 0.21]
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Analysis 1.1. Comparison 1 Intervention versus control, Outcome 1 EORTC QLQ C30 - Physical function
(medium-term follow-up).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 1 EORTC QLQ C30 - Physical function (medium-term follow-up)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 64.21 (26.14) 21 53.25 (18.64) 39.4 % 10.96 [ -2.19, 24.11 ]
Humphris 2012 44 64 (30.3) 30 72 (30.4) 37.9 % -8.00 [ -22.09, 6.09 ]
Katz 2004 10 87 (22.4) 9 65 (33.4) 22.7 % 22.00 [ -3.86, 47.86 ]
Total (95% CI) 78 60 100.0 % 6.28 [ -10.05, 22.60 ]
Heterogeneity: Tau2 = 131.24; Chi2 = 5.71, df = 2 (P = 0.06); I2 =65%
Test for overall effect: Z = 0.75 (P = 0.45)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours intervention
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Analysis 1.2. Comparison 1 Intervention versus control, Outcome 2 EORTCQLQ C30 - Emotional function
(medium-term follow-up).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 2 EORTC QLQ C30 - Emotional function (medium-term follow-up)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 75.19 (21.3) 21 69.16 (16.47) 44.2 % 6.03 [ -5.03, 17.09 ]
Humphris 2012 44 75.3 (24.6) 30 77.2 (21.6) 48.0 % -1.90 [ -12.51, 8.71 ]
Katz 2004 10 76 (27.1) 9 66 (30.7) 7.9 % 10.00 [ -16.16, 36.16 ]
Total (95% CI) 78 60 100.0 % 2.54 [ -4.81, 9.89 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.37, df = 2 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours intervention
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Analysis 1.3. Comparison 1 Intervention versus control, Outcome 3 EORTC QLQ C30 - Social function
(medium-term follow-up).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 3 EORTC QLQ C30 - Social function (medium-term follow-up)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 62.28 (23.92) 21 60.71 (25.36) 38.7 % 1.57 [ -12.89, 16.03 ]
Humphris 2012 44 77.6 (31.1) 30 82.7 (26.4) 46.7 % -5.10 [ -18.28, 8.08 ]
Katz 2004 10 72 (32.4) 9 76 (18.8) 14.6 % -4.00 [ -27.54, 19.54 ]
Total (95% CI) 78 60 100.0 % -2.36 [ -11.36, 6.65 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.47, df = 2 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 0.51 (P = 0.61)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours intervention
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Analysis 1.4. Comparison 1 Intervention versus control, Outcome 4 EORTC QLQ C30 - Role function
(medium-term follow-up).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 4 EORTC QLQ C30 - Role function (medium-term follow-up)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 62.39 (26.33) 21 60.21 (29.16) 13.0 % 2.18 [ -14.15, 18.51 ]
Humphris 2012 44 87.1 (13.8) 30 89.4 (14.1) 82.4 % -2.30 [ -8.79, 4.19 ]
Katz 2004 10 78 (34.3) 9 74 (26.5) 4.6 % 4.00 [ -23.42, 31.42 ]
Total (95% CI) 78 60 100.0 % -1.43 [ -7.31, 4.46 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.41, df = 2 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.47 (P = 0.63)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours intervention
40Psychosocial interventions for patients with head and neck cancer (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.5. Comparison 1 Intervention versus control, Outcome 5 EORTC QLQ C30 - Global quality of
life (medium-term follow-up).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 5 EORTC QLQ C30 - Global quality of life (medium-term follow-up)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 61.15 (25.17) 21 52.46 (21.71) 32.0 % 8.69 [ -5.01, 22.39 ]
Humphris 2012 44 66.6 (19.6) 30 74.4 (18.6) 45.2 % -7.80 [ -16.62, 1.02 ]
Katz 2004 10 58 (20.2) 9 66 (20.6) 22.9 % -8.00 [ -26.38, 10.38 ]
Total (95% CI) 78 60 100.0 % -2.57 [ -13.54, 8.40 ]
Heterogeneity: Tau2 = 49.11; Chi2 = 4.18, df = 2 (P = 0.12); I2 =52%
Test for overall effect: Z = 0.46 (P = 0.65)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours intervention
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Analysis 1.6. Comparison 1 Intervention versus control, Outcome 6 EORTC QLQ C30 - Cognitive function
(medium-term follow-up).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 6 EORTC QLQ C30 - Cognitive function (medium-term follow-up)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 79.11 (19.37) 21 74.74 (25.19) 31.4 % 4.37 [ -8.90, 17.64 ]
Humphris 2012 44 79.1 (24.4) 30 87.7 (18.5) 49.9 % -8.60 [ -18.39, 1.19 ]
Katz 2004 10 82 (21.4) 9 89 (18.6) 18.7 % -7.00 [ -24.99, 10.99 ]
Total (95% CI) 78 60 100.0 % -4.23 [ -12.48, 4.03 ]
Heterogeneity: Tau2 = 10.64; Chi2 = 2.46, df = 2 (P = 0.29); I2 =19%
Test for overall effect: Z = 1.00 (P = 0.32)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours intervention
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Analysis 1.7. Comparison 1 Intervention versus control, Outcome 7 EORTC QLQ C30 - Cognitive function
(end of intervention).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 7 EORTC QLQ C30 - Cognitive function (end of intervention)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 79.11 (19.37) 21 74.74 (25.19) 32.8 % 4.37 [ -8.90, 17.64 ]
Humphris 2012 46 84.7 (21) 31 82.7 (24.1) 53.0 % 2.00 [ -8.43, 12.43 ]
Katz 2004 10 76 (18.84) 9 74 (25.15) 14.2 % 2.00 [ -18.16, 22.16 ]
Total (95% CI) 80 61 100.0 % 2.78 [ -4.82, 10.37 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.08, df = 2 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours intervention
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Analysis 1.8. Comparison 1 Intervention versus control, Outcome 8 EORTC QLQ C30 - Physical function
(end of intervention).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 8 EORTC QLQ C30 - Physical function (end of intervention)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 64.21 (26.14) 21 53.25 (18.64) 46.6 % 10.96 [ -2.19, 24.11 ]
Humphris 2012 46 65.6 (25.1) 31 64.5 (32.1) 44.7 % 1.10 [ -12.33, 14.53 ]
Katz 2004 10 76 (26.33) 9 63 (39) 8.8 % 13.00 [ -17.26, 43.26 ]
Total (95% CI) 80 61 100.0 % 6.74 [ -2.24, 15.71 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.24, df = 2 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.47 (P = 0.14)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours intervention
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Analysis 1.9. Comparison 1 Intervention versus control, Outcome 9 EORTCQLQ C30 - Emotional function
(end of intervention).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 9 EORTC QLQ C30 - Emotional function (end of intervention)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 75.19 (21.3) 21 69.16 (16.47) 49.1 % 6.03 [ -5.03, 17.09 ]
Humphris 2012 46 76.2 (22.8) 31 73.6 (28.2) 42.3 % 2.60 [ -9.31, 14.51 ]
Katz 2004 10 67 (28.87) 9 66 (29.6) 8.6 % 1.00 [ -25.35, 27.35 ]
Total (95% CI) 80 61 100.0 % 4.15 [ -3.60, 11.89 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.23, df = 2 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours intervention
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Analysis 1.10. Comparison 1 Intervention versus control, Outcome 10 EORTC QLQ C30 - Social function
(end of intervention).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 10 EORTC QLQ C30 - Social function (end of intervention)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 62.28 (23.92) 21 60.71 (25.36) 38.8 % 1.57 [ -12.89, 16.03 ]
Humphris 2012 46 76.4 (31.9) 31 82.7 (24.1) 51.7 % -6.30 [ -18.83, 6.23 ]
Katz 2004 10 57 (31.62) 9 61 (33.3) 9.5 % -4.00 [ -33.28, 25.28 ]
Total (95% CI) 80 61 100.0 % -3.03 [ -12.04, 5.98 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.65, df = 2 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Intervention versus control, Outcome 11 EORTC QLQ C30 - Role function
(end of intervention).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 11 EORTC QLQ C30 - Role function (end of intervention)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 62.39 (26.33) 21 60.21 (29.16) 14.3 % 2.18 [ -14.15, 18.51 ]
Humphris 2012 46 84.7 (15.2) 31 84.4 (14.8) 81.8 % 0.30 [ -6.51, 7.11 ]
Katz 2004 10 43 (44.96) 9 24 (20.6) 4.0 % 19.00 [ -11.95, 49.95 ]
Total (95% CI) 80 61 100.0 % 1.31 [ -4.85, 7.47 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.35, df = 2 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 0.42 (P = 0.68)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Intervention versus control, Outcome 12 EORTC QLQ C30 - Global quality of
life (end of intervention).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 12 EORTC QLQ C30 - Global quality of life (end of intervention)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bai 2004 24 61.15 (25.17) 21 52.46 (21.71) 26.5 % 8.69 [ -5.01, 22.39 ]
Humphris 2012 46 65.9 (20.7) 31 66.3 (20.5) 56.5 % -0.40 [ -9.77, 8.97 ]
Katz 2004 10 56 (25.78) 9 61 (9.32) 17.0 % -5.00 [ -22.10, 12.10 ]
Total (95% CI) 80 61 100.0 % 1.23 [ -5.82, 8.27 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.77, df = 2 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 0.34 (P = 0.73)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Intervention versus control, Outcome 13 Anxiety (medium-term follow-up 3
to 4 months).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 13 Anxiety (medium-term follow-up 3 to 4 months)







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Allison 2012 31 6.4 (3.1) 30 6.5 (3.6) 39.8 % -0.03 [ -0.53, 0.47 ]
Humphris 2012 46 5.41 (4.75) 31 5.52 (4.4) 48.4 % -0.02 [ -0.48, 0.43 ]
Katz 2004 (1) 10 36 (11.24) 9 44 (17.2) 11.8 % -0.53 [ -1.45, 0.39 ]
Total (95% CI) 87 70 100.0 % -0.09 [ -0.40, 0.23 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.02, df = 2 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 0.53 (P = 0.59)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Intervention versus control, Outcome 14 Anxiety (end of intervention).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 14 Anxiety (end of intervention)







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Allison 2012 31 6.4 (3.1) 30 6.5 (3.6) 39.7 % -0.03 [ -0.53, 0.47 ]
Humphris 2012 46 6.09 (4.7) 31 6.68 (5.6) 48.1 % -0.11 [ -0.57, 0.34 ]
Katz 2004 (1) 10 36 (10.48) 9 39 (18.09) 12.2 % -0.20 [ -1.10, 0.71 ]
Total (95% CI) 87 70 100.0 % -0.09 [ -0.41, 0.23 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.12, df = 2 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.56 (P = 0.57)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Intervention versus control, Outcome 15 Depression (medium term follow-up
3 to 6 months).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 15 Depression (medium term follow-up 3 to 6 months)







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Allison 2012 31 5.1 (4) 30 5.7 (4.1) 18.4 % -0.15 [ -0.65, 0.36 ]
Duffy 2006 90 3.05 (2.63) 88 3.16 (2.38) 53.8 % -0.04 [ -0.34, 0.25 ]
Humphris 2012 46 4.54 (3.93) 31 3.74 (3.06) 22.3 % 0.22 [ -0.24, 0.68 ]
Katz 2004 10 13 (8.08) 9 20 (17.3) 5.5 % -0.50 [ -1.42, 0.41 ]
Total (95% CI) 177 158 100.0 % -0.03 [ -0.24, 0.19 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.39, df = 3 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 0.27 (P = 0.79)
Test for subgroup differences: Not applicable
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Analysis 1.16. Comparison 1 Intervention versus control, Outcome 16 Depression (end of intervention).
Review: Psychosocial interventions for patients with head and neck cancer
Comparison: 1 Intervention versus control
Outcome: 16 Depression (end of intervention)







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Allison 2012 31 5.1 (4) 30 5.7 (4.1) 18.4 % -0.15 [ -0.65, 0.36 ]
Duffy 2006 90 3.05 (2.63) 88 3.16 (2.38) 53.8 % -0.04 [ -0.34, 0.25 ]
Humphris 2012 46 5.22 (4.07) 31 4.19 (3.56) 22.2 % 0.26 [ -0.19, 0.72 ]
Katz 2004 10 18 (10.54) 9 21 (15.47) 5.7 % -0.22 [ -1.12, 0.69 ]
Total (95% CI) 177 158 100.0 % 0.00 [ -0.22, 0.21 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.91, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.04 (P = 0.97)
Test for subgroup differences: Not applicable
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A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL Cochrane ENT Disorders
Group Trials Register
PubMed EMBASE (Ovid)
#1 MeSH descriptor Head and
NeckNeoplasms, this termonly
#2 MeSH descriptor Otorhi-
nolaryngologic Neoplasms ex-
plode all trees
#3 MeSH descriptor Neck Dis-
section explode all trees
#4 MeSH descriptor Laryngec-
tomy explode all trees
#5 MeSH descriptor Neo-
plasms explode all trees
(HNSCC OR SCCHNOR la-
ryngectom* OR (neck AND
dissect*) OR cancer* OR car-
cinoma* OR neoplas* OR tu-
mor* OR tumour* OR malig-
nan* OR SCCA) AND (coun-
sel* OR psychoeducat* OR ed-
ucat* OR psychological OR
coping OR psychotherap* OR
psychosocial* OR psychoana-




plasms” [Mesh] OR “NeckDis-
section” [Mesh]OR “Laryngec-
tomy” [MeSH] OR HNSCC
ORSCCHNOR laryngectom*
OR (neck AND dissect*)
#3 “Neoplasms” [Mesh] OR
1 exp “head and neck cancer”/
2 exp neck dissection/
3 exp laryngectomy/
4 (HNSCC or SCCHN or la-
ryngectom* or (neck and dis-
sect*)).tw.
5 exp neoplasm/
6 (cancer or cancers or cancer-
ous or carcinoma* or neoplas*
or tumor* or tumour* or malig-
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(Continued)
#6 (cancer* OR carcinoma*
OR neoplas* OR tumor* OR
tumour* OR malignan* OR
SCCA)
#7
(“head and neck”:ti OR “head
neck”:ti OR “head-neck”:ti OR
“head-and-neck”:ti OR oral:
ti OR oropharyn*:ti OR hy-
popharyn*:ti or laryn*:ti OR
nasopharyn*:ti OR pharyn*:ti
OR throat:ti OR mouth:ti)
#8 (#5 OR #6) AND #7
#9 HNSCC OR SCCHN OR
laryngectom* OR (neck AND
dissect*)
#10 #1 OR #2 OR #3 OR #4
OR #8 OR #9
#11MeSH descriptor Counsel-
ing explode all trees
#12 MeSH descriptor Psy-
chotherapy explode all trees
#13 MeSH descriptor Self-
Help Groups explode all trees
#14 MeSH descriptor Mind-
BodyTherapies explode all trees
#15 MeSH descriptor Religion
and Psychology explode all trees
#16 MeSH descriptor Patient
Education as Topic explode all
trees
#17 MeSH descriptor Personal
Satisfaction explode all trees
#18 MeSH descriptor Mental
Health explode all trees
#19 MeSH descriptor Quality
of Life explode all trees with
qualifier: PX
#20 MeSH descriptor Emo-
tions explode all trees with qual-
ifier: TH
#21 MeSH descriptor Stress,
Psychological explode all trees
with qualifier: TH
#22 MeSH descriptor Depres-
sion explode all trees with qual-
ifier: TH
#23 counsel*:ti OR psychoe-
ducat*:ti OR coping:ti OR
lytic OR social OR peer OR
help OR cognitive OR relax*
OR family OR couple OR bib-
liotherap* OR art OR music
OR colour OR color OR relig*
OR prayer* OR spiritual* OR
meditat* OR aromatherap*)
(cancer OR cancers OR cancer-
ous OR carcinoma* OR neo-
plas* OR tumor* OR tumour*
OR malignan* OR SCCA)
#4 (“head and neck” [ti] OR
“head neck” [ti] OR “head-
neck” [ti] OR “head-and-neck”
[ti]ORoral [ti]ORoropharyn*
[ti] OR hypopharyn* [ti] or
laryn* [ti] OR nasopharyn* [ti]
OR pharyn* [ti] OR throat [ti]
OR mouth [ti])
#5 #3 AND #4
#6 #1 OR #2 OR #5




pies” [Mesh] OR “Religion and
Psychology” [Mesh] OR “Per-
sonal Satisfaction” [MeSH] OR
“Mental Health” [Mesh] OR
“Quality of Life/psychology”
[Mesh] OR “Emotions/ther-
apy” [Mesh] OR “Stress, Psy-
chological/therapy” [Mesh]OR
“Depression/therapy” [Mesh]
#8 “Patient Education as
Topic”[Mesh]
#9 counsel* [ti] OR psychoe-
ducat* [ti] OR educat* [ti]
OR coping [ti] OR (psycho-
logical [ti] AND (therap* [ti]
OR treatment* [ti] OR out-
come* [ti] OR intervention*
[ti]))ORpsychotherap* [ti]OR
psychosocial* [ti] OR psycho-
analytic [ti] OR ((social [ti] OR
peer [ti] OR group [ti]) AND
support [ti]) OR (self [ti] AND
help [ti]) OR (cognitive [ti]
AND (therap* [ti] OR behav*
[ti])) OR relax* [ti] OR ((fam-
ily [ti] OR couple [ti]) AND
therap* [ti])
#10 bibliotherap* [ti] OR ((art
[ti] OR music [ti] OR colour
[ti] OR color [ti]) AND therap*
nan* or SCCA).tw.
7 5 or 6
8 ((head and neck) or oral
or oropharyn* or hypopharyn*
or laryn* or nasopharyn* or
pharyn* or throat ormouth).tw.
9 7 and 8
10 1 or 2 or 3 or 4 or 9
11 exp psychotherapy/
12 animal assisted therapy/ or
counseling/
13 exp self help/
14 exp mental health/
15 exp religion/
16 [exp emotion/th [Therapy]]
17 [exp stress/th [Therapy]]
18 [exp depression/th [Ther-
apy]]
19 (counsel* or psychoeducat*
or educat* or coping or (psy-
chological and (therap* or treat-
ment* or outcome* or interven-
tion*)) or psychotherap* or psy-
chosocial* or psychoanalytic or
((social or peer or group) and
support) or (self and help) or
(cognitive and (therap* or be-
hav*)) or relax* or ((family or
couple) and therap*) or bib-
liotherap* or ((art or music or
colour or color) and therap*) or
relig* or prayer* or spiritual* or
meditat* or aromatherap*).ti.
20 exp aromatherapy/ or exp
reiki/ or exp spiritual healing/
21 11 or 12 or 13 or 14 or 15
or 16 or 17 or 18 or 19 or 20
22 10 and 21
53Psychosocial interventions for patients with head and neck cancer (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
educat*:ti OR (psychological:
ti AND (therap*:ti OR treat-
ment*:ti OR
outcome*:ti OR intervention*:
ti)) OR psychotherap*:ti OR
psychosocial*:ti OR psychoan-
alytic:ti OR ((social:ti OR peer:
ti OR group:ti) AND support:
ti) OR (self:ti ANDhelp:ti)OR
(cognitive:ti AND (therap*:ti
ORbehav*:ti))OR relax*:tiOR
((family:ti OR couple:ti) AND
therap*:ti)
#24 bibliotherap*:ti OR ((art:ti
OR music:ti OR colour:ti OR
color:ti) AND therap*:ti) OR
relig*:tiORprayer*:tiOR spiri-
tual*:ti ORmeditat*:ti OR aro-
matherap*:ti
#25 #11 OR #12 OR #13 OR
#14 OR #15 OR #16 OR #17
OR #18 OR #19 OR #20 OR
#21 OR #22 OR #23 OR #24
#26 #10 AND #25
[ti]) OR relig* [ti] OR prayer*
[ti] OR spiritual* [ti] OR med-
itat* [ti] OR aromatherap* [ti]
#11 #7 OR #8 OR #9 OR #10
#12 #6 AND #11
Web of Science/BIOSIS Pre-
views (Web of Knowledge)
CINAHL (EBSCO) CAB Abstracts (Ovid) ICTRP
#1 TS=(HNSCC OR SCCHN
OR laryngectom* OR (neck
AND dissect*))
#2 TS=(cancer* OR carci-
noma* OR neoplas* OR tu-
mor* OR tumour* OR malig-
nan* OR SCCA)
#3 TS=((head and neck) or oral
or oropharyn* or hypopharyn*
or laryn* or nasopharyn* or
pharyn* or throat or mouth)
#4 #3 AND #2
#5 #4 OR #1
#6 TI=(counsel* OR psychoed-




alytic OR ((social OR peer
OR group) AND support) OR
(self AND help) OR (cogni-
S1 (MH “Head and Neck Neo-




S3 TX (HNSCC OR SCCHN
OR laryngectom* OR (neck
AND dissect*))
S4 S1 or S2 or S3
S5 (MH “Neoplasms+”)
S6TX (cancer*OR carcinoma*
OR neoplas* OR tumor* OR
tumour* OR malignan* OR
SCCA)
S7 S5 or S6
S8 TX ((head and neck) or oral
or oropharyn* or hypopharyn*
or laryn* or nasopharyn* or
pharyn* or throat or mouth)
S9 S7 and S8
S10 S4 or S9
1 exp ”head and neck cancer
2 exp laryngeal cancer
3 (HNSCC or SCCHN or la-
ryngectom* or (neck and dis-
sect*)).tw.
4 exp neoplasm/
5 (cancer or cancers or cancer-
ous or carcinoma* or neoplas*
or tumor* or tumour* or malig-
nan* or SCCA).tw.
6 4 or 5
7 ((head and neck) or oral
or oropharyn* or hypopharyn*
or laryn* or nasopharyn* or
pharyn* or throat ormouth).tw.
8 6 and 7
9 1 or 2 or 3 or 8
10 exp psychotherapy/
11exp counseling/
12 exp self help/
13 exp mental health/
head AND neck AND psych*
OR head AND neck AND
cousel* OR head AND neck
AND coping OR head AND
neck AND stress* OR head
AND neck AND depression
ORhnscc ANDpsych*ORhn-
scc AND counsel* OR hnscc
AND stress* OR hnscc AND
depress OR hnscc AND coping
54Psychosocial interventions for patients with head and neck cancer (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
tive AND (therap* OR behav*)
) OR relax* OR ((family OR
couple) AND therap*) OR bib-
liotherap* OR ((art OR mu-
sic OR colour OR color) AND
therap*) OR relig* OR prayer*
OR spiritual* ORmeditat* OR
aromatherap*)




S13 (MH “Support Groups+”)
S14 (MH “Patient Educa-
tion+”)
S15 (MH “Mental Health”)
S16 (MH “Religion and Psy-
chology+”)





ucat* OR educat* OR (psycho-
logical AND(therap*OR treat-
ment*)) OR psychotherap* OR
psychosocial* OR psychoan-
alytic OR ((social OR peer
OR group) AND support) OR
(self AND help) OR (cogni-
tive AND (therap* OR behav*)
) OR relax* OR ((family OR
couple) AND therap*)OR bib-
liotherap* OR ((art OR mu-
sic OR colour OR color) AND
therap*) OR relig* OR prayer*
OR spiritual* ORmeditat* OR
aromatherap*)
S22 S11 or S12 or S13 or S14
or S15 or S16 or S17 or S18 or
S19 or S20 or S21
S23 S10 and S22
14 exp religion/
15 (counsel* or psychoeducat*
or educat* or coping or (psy-
chological and (therap* or treat-
ment* or outcome* or interven-
tion*)) or psychotherap* or psy-
chosocial* or psychoanalytic or
((social or peer or group) and
support) or (self and help) or
(cognitive and (therap* or be-
hav*)) or relax* or ((family or
couple) and therap*) or bib-
liotherap* or ((art or music or
colour or color) and therap*) or
relig* or prayer* or spiritual* or
meditat* or aromatherap*).ti.
16 exp aromatherapy/
17 10 or 11 or 12 or 13 or 14
or 15 or 16
18 9 and 17
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